New York, June 17, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Reporter Gene Assay Industry" - https://www.reportlinker.com/p06032765/?utm_source=GNW
1 Billion by 2027, growing at aCAGR of 8.7% over the period 2020-2027. Assay Kits, one of the segments analyzed in the report, is projected to record 9.1% CAGR and reach US$2.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 7.6% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $506.4 Million, While China is Forecast to Grow at 8.1% CAGR
- The Reporter Gene Assay market in the U.S. is estimated at US$506.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$532.6 Million by the year 2027 trailing a CAGR of 8.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 7.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.
- Select Competitors (Total 32 Featured) -
- Abcam PLC
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Biotium
- Danaher Corporation
- Genecopoeia, Inc.
- Geno Technology, Inc.
- Invivogen
- Merck KGaA
- Perkinelmer
- Promega Corporation
- Promocell
- Thermo Fisher Scientific, Inc.
Read the full report: https://www.reportlinker.com/p06032765/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Reporter Gene
Assay by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 2: World 7-Year Perspective for Reporter Gene Assay by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2020 & 2027
Table 3: World Current & Future Analysis for Assay Kits by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 4: World 7-Year Perspective for Assay Kits by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2020 & 2027
Table 5: World Current & Future Analysis for Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 6: World 7-Year Perspective for Reagents by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2020 & 2027
Table 7: World Current & Future Analysis for Contract Research
Organizations by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 8: World 7-Year Perspective for Contract Research
Organizations by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2020 & 2027
Table 9: World Current & Future Analysis for Academic &
Research Institutes by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 10: World 7-Year Perspective for Academic & Research
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2020 & 2027
Table 11: World Current & Future Analysis for Pharma & Biotech
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 12: World 7-Year Perspective for Pharma & Biotech
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2020 & 2027
Table 13: World Current & Future Analysis for Hospitals &
Diagnostic Laboratories by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 14: World 7-Year Perspective for Hospitals & Diagnostic
Laboratories by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2020 & 2027
Table 15: World Current & Future Analysis for Cell Signaling
Pathways by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 16: World 7-Year Perspective for Cell Signaling Pathways
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027
Table 17: World Current & Future Analysis for Promoter
Structural & Functional Analysis by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 18: World 7-Year Perspective for Promoter Structural &
Functional Analysis by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2020 & 2027
Table 19: World Current & Future Analysis for Gene Regulation
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 20: World 7-Year Perspective for Gene Regulation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027
Table 21: World Current & Future Analysis for Protein
Interaction by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 22: World 7-Year Perspective for Protein Interaction by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 23: USA Current & Future Analysis for Reporter Gene Assay
by Product Type - Assay Kits and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 24: USA 7-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for Assay
Kits and Reagents for the Years 2020 & 2027
Table 25: USA Current & Future Analysis for Reporter Gene Assay
by End-Use - Contract Research Organizations, Academic &
Research Institutes, Pharma & Biotech Companies and Hospitals &
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 26: USA 7-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations, Academic & Research Institutes, Pharma &
Biotech Companies and Hospitals & Diagnostic Laboratories for
the Years 2020 & 2027
Table 27: USA Current & Future Analysis for Reporter Gene Assay
by Application - Cell Signaling Pathways, Promoter Structural &
Functional Analysis, Gene Regulation and Protein Interaction -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 28: USA 7-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Cell
Signaling Pathways, Promoter Structural & Functional Analysis,
Gene Regulation and Protein Interaction for the Years 2020 &
2027
CANADA
Table 29: Canada Current & Future Analysis for Reporter Gene
Assay by Product Type - Assay Kits and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 30: Canada 7-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for Assay
Kits and Reagents for the Years 2020 & 2027
Table 31: Canada Current & Future Analysis for Reporter Gene
Assay by End-Use - Contract Research Organizations, Academic &
Research Institutes, Pharma & Biotech Companies and Hospitals &
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 32: Canada 7-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations, Academic & Research Institutes, Pharma &
Biotech Companies and Hospitals & Diagnostic Laboratories for
the Years 2020 & 2027
Table 33: Canada Current & Future Analysis for Reporter Gene
Assay by Application - Cell Signaling Pathways, Promoter
Structural & Functional Analysis, Gene Regulation and Protein
Interaction - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 34: Canada 7-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Cell
Signaling Pathways, Promoter Structural & Functional Analysis,
Gene Regulation and Protein Interaction for the Years 2020 &
2027
JAPAN
Table 35: Japan Current & Future Analysis for Reporter Gene
Assay by Product Type - Assay Kits and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 36: Japan 7-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for Assay
Kits and Reagents for the Years 2020 & 2027
Table 37: Japan Current & Future Analysis for Reporter Gene
Assay by End-Use - Contract Research Organizations, Academic &
Research Institutes, Pharma & Biotech Companies and Hospitals &
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 38: Japan 7-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations, Academic & Research Institutes, Pharma &
Biotech Companies and Hospitals & Diagnostic Laboratories for
the Years 2020 & 2027
Table 39: Japan Current & Future Analysis for Reporter Gene
Assay by Application - Cell Signaling Pathways, Promoter
Structural & Functional Analysis, Gene Regulation and Protein
Interaction - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 40: Japan 7-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Cell
Signaling Pathways, Promoter Structural & Functional Analysis,
Gene Regulation and Protein Interaction for the Years 2020 &
2027
CHINA
Table 41: China Current & Future Analysis for Reporter Gene
Assay by Product Type - Assay Kits and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 42: China 7-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for Assay
Kits and Reagents for the Years 2020 & 2027
Table 43: China Current & Future Analysis for Reporter Gene
Assay by End-Use - Contract Research Organizations, Academic &
Research Institutes, Pharma & Biotech Companies and Hospitals &
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 44: China 7-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations, Academic & Research Institutes, Pharma &
Biotech Companies and Hospitals & Diagnostic Laboratories for
the Years 2020 & 2027
Table 45: China Current & Future Analysis for Reporter Gene
Assay by Application - Cell Signaling Pathways, Promoter
Structural & Functional Analysis, Gene Regulation and Protein
Interaction - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 46: China 7-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Cell
Signaling Pathways, Promoter Structural & Functional Analysis,
Gene Regulation and Protein Interaction for the Years 2020 &
2027
EUROPE
Table 47: Europe Current & Future Analysis for Reporter Gene
Assay by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 48: Europe 7-Year Perspective for Reporter Gene Assay by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2020 & 2027
Table 49: Europe Current & Future Analysis for Reporter Gene
Assay by Product Type - Assay Kits and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 50: Europe 7-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for Assay
Kits and Reagents for the Years 2020 & 2027
Table 51: Europe Current & Future Analysis for Reporter Gene
Assay by End-Use - Contract Research Organizations, Academic &
Research Institutes, Pharma & Biotech Companies and Hospitals &
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 52: Europe 7-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations, Academic & Research Institutes, Pharma &
Biotech Companies and Hospitals & Diagnostic Laboratories for
the Years 2020 & 2027
Table 53: Europe Current & Future Analysis for Reporter Gene
Assay by Application - Cell Signaling Pathways, Promoter
Structural & Functional Analysis, Gene Regulation and Protein
Interaction - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 54: Europe 7-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Cell
Signaling Pathways, Promoter Structural & Functional Analysis,
Gene Regulation and Protein Interaction for the Years 2020 &
2027
FRANCE
Table 55: France Current & Future Analysis for Reporter Gene
Assay by Product Type - Assay Kits and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 56: France 7-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for Assay
Kits and Reagents for the Years 2020 & 2027
Table 57: France Current & Future Analysis for Reporter Gene
Assay by End-Use - Contract Research Organizations, Academic &
Research Institutes, Pharma & Biotech Companies and Hospitals &
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 58: France 7-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations, Academic & Research Institutes, Pharma &
Biotech Companies and Hospitals & Diagnostic Laboratories for
the Years 2020 & 2027
Table 59: France Current & Future Analysis for Reporter Gene
Assay by Application - Cell Signaling Pathways, Promoter
Structural & Functional Analysis, Gene Regulation and Protein
Interaction - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 60: France 7-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Cell
Signaling Pathways, Promoter Structural & Functional Analysis,
Gene Regulation and Protein Interaction for the Years 2020 &
2027
GERMANY
Table 61: Germany Current & Future Analysis for Reporter Gene
Assay by Product Type - Assay Kits and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 62: Germany 7-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for Assay
Kits and Reagents for the Years 2020 & 2027
Table 63: Germany Current & Future Analysis for Reporter Gene
Assay by End-Use - Contract Research Organizations, Academic &
Research Institutes, Pharma & Biotech Companies and Hospitals &
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 64: Germany 7-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations, Academic & Research Institutes, Pharma &
Biotech Companies and Hospitals & Diagnostic Laboratories for
the Years 2020 & 2027
Table 65: Germany Current & Future Analysis for Reporter Gene
Assay by Application - Cell Signaling Pathways, Promoter
Structural & Functional Analysis, Gene Regulation and Protein
Interaction - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 66: Germany 7-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Cell
Signaling Pathways, Promoter Structural & Functional Analysis,
Gene Regulation and Protein Interaction for the Years 2020 &
2027
ITALY
Table 67: Italy Current & Future Analysis for Reporter Gene
Assay by Product Type - Assay Kits and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 68: Italy 7-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for Assay
Kits and Reagents for the Years 2020 & 2027
Table 69: Italy Current & Future Analysis for Reporter Gene
Assay by End-Use - Contract Research Organizations, Academic &
Research Institutes, Pharma & Biotech Companies and Hospitals &
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 70: Italy 7-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations, Academic & Research Institutes, Pharma &
Biotech Companies and Hospitals & Diagnostic Laboratories for
the Years 2020 & 2027
Table 71: Italy Current & Future Analysis for Reporter Gene
Assay by Application - Cell Signaling Pathways, Promoter
Structural & Functional Analysis, Gene Regulation and Protein
Interaction - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 72: Italy 7-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Cell
Signaling Pathways, Promoter Structural & Functional Analysis,
Gene Regulation and Protein Interaction for the Years 2020 &
2027
UNITED KINGDOM
Table 73: UK Current & Future Analysis for Reporter Gene Assay
by Product Type - Assay Kits and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 74: UK 7-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for Assay
Kits and Reagents for the Years 2020 & 2027
Table 75: UK Current & Future Analysis for Reporter Gene Assay
by End-Use - Contract Research Organizations, Academic &
Research Institutes, Pharma & Biotech Companies and Hospitals &
Diagnostic Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 76: UK 7-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations, Academic & Research Institutes, Pharma &
Biotech Companies and Hospitals & Diagnostic Laboratories for
the Years 2020 & 2027
Table 77: UK Current & Future Analysis for Reporter Gene Assay
by Application - Cell Signaling Pathways, Promoter Structural &
Functional Analysis, Gene Regulation and Protein Interaction -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 78: UK 7-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Cell
Signaling Pathways, Promoter Structural & Functional Analysis,
Gene Regulation and Protein Interaction for the Years 2020 &
2027
REST OF EUROPE
Table 79: Rest of Europe Current & Future Analysis for Reporter
Gene Assay by Product Type - Assay Kits and Reagents -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 80: Rest of Europe 7-Year Perspective for Reporter Gene
Assay by Product Type - Percentage Breakdown of Value Sales for
Assay Kits and Reagents for the Years 2020 & 2027
Table 81: Rest of Europe Current & Future Analysis for Reporter
Gene Assay by End-Use - Contract Research Organizations,
Academic & Research Institutes, Pharma & Biotech Companies and
Hospitals & Diagnostic Laboratories - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 82: Rest of Europe 7-Year Perspective for Reporter Gene
Assay by End-Use - Percentage Breakdown of Value Sales for
Contract Research Organizations, Academic & Research
Institutes, Pharma & Biotech Companies and Hospitals &
Diagnostic Laboratories for the Years 2020 & 2027
Table 83: Rest of Europe Current & Future Analysis for Reporter
Gene Assay by Application - Cell Signaling Pathways, Promoter
Structural & Functional Analysis, Gene Regulation and Protein
Interaction - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 84: Rest of Europe 7-Year Perspective for Reporter Gene
Assay by Application - Percentage Breakdown of Value Sales for
Cell Signaling Pathways, Promoter Structural & Functional
Analysis, Gene Regulation and Protein Interaction for the Years
2020 & 2027
ASIA-PACIFIC
Table 85: Asia-Pacific Current & Future Analysis for Reporter
Gene Assay by Product Type - Assay Kits and Reagents -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 86: Asia-Pacific 7-Year Perspective for Reporter Gene
Assay by Product Type - Percentage Breakdown of Value Sales for
Assay Kits and Reagents for the Years 2020 & 2027
Table 87: Asia-Pacific Current & Future Analysis for Reporter
Gene Assay by End-Use - Contract Research Organizations,
Academic & Research Institutes, Pharma & Biotech Companies and
Hospitals & Diagnostic Laboratories - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 88: Asia-Pacific 7-Year Perspective for Reporter Gene
Assay by End-Use - Percentage Breakdown of Value Sales for
Contract Research Organizations, Academic & Research
Institutes, Pharma & Biotech Companies and Hospitals &
Diagnostic Laboratories for the Years 2020 & 2027
Table 89: Asia-Pacific Current & Future Analysis for Reporter
Gene Assay by Application - Cell Signaling Pathways, Promoter
Structural & Functional Analysis, Gene Regulation and Protein
Interaction - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 90: Asia-Pacific 7-Year Perspective for Reporter Gene
Assay by Application - Percentage Breakdown of Value Sales for
Cell Signaling Pathways, Promoter Structural & Functional
Analysis, Gene Regulation and Protein Interaction for the Years
2020 & 2027
REST OF WORLD
Table 91: Rest of World Current & Future Analysis for Reporter
Gene Assay by Product Type - Assay Kits and Reagents -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 92: Rest of World 7-Year Perspective for Reporter Gene
Assay by Product Type - Percentage Breakdown of Value Sales for
Assay Kits and Reagents for the Years 2020 & 2027
Table 93: Rest of World Current & Future Analysis for Reporter
Gene Assay by End-Use - Contract Research Organizations,
Academic & Research Institutes, Pharma & Biotech Companies and
Hospitals & Diagnostic Laboratories - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 94: Rest of World 7-Year Perspective for Reporter Gene
Assay by End-Use - Percentage Breakdown of Value Sales for
Contract Research Organizations, Academic & Research
Institutes, Pharma & Biotech Companies and Hospitals &
Diagnostic Laboratories for the Years 2020 & 2027
Table 95: Rest of World Current & Future Analysis for Reporter
Gene Assay by Application - Cell Signaling Pathways, Promoter
Structural & Functional Analysis, Gene Regulation and Protein
Interaction - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 96: Rest of World 7-Year Perspective for Reporter Gene
Assay by Application - Percentage Breakdown of Value Sales for
Cell Signaling Pathways, Promoter Structural & Functional
Analysis, Gene Regulation and Protein Interaction for the Years
2020 & 2027
IV. COMPETITION
Total Companies Profiled: 32
Read the full report: https://www.reportlinker.com/p06032765/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________